HOME > SCIENCE > TESTING BY DEVICE TYPE > GASTROENTEROLOGIC LOCATIONS | CONTACT US | SITEMAP
-
Testing by Device Type

Gastroenterologic

These devices include devices in contact with any part of the gastro-intestinal tract such as naso-gastric tubes, esophageal instruments or dilators, and devices placed in or around the stomach or intestine. Depending upon the end use, the amount of time for patient exposure will vary. Some devices in this category are considered permanent contact.

Standards and Regulation

Most gastro-intestinal devices are considered externally communicating, with the exception of those actually implanted. First consideration should be given to vertical standards (an FDA guideline or ISO standard in use for a specific device). In the absence of such guidance, ISO 10993 should be consulted to determine potential areas of concern for these devices. Each device should be examined on it's own merits. In some cases, prior data may be available from suppliers or in the literature, or there may be efficacy or functionality testing in progress that can be used to satisfy a portion of the safety requirements.

Test Categories

The following tests are considered for gastro-intestinal devices:

Characterization of Materials

Materials having long-term exposure are likely to undergo change since the gastro-intestinal environment is harsh and may contain enzymes and chemicals in the high and low pH ranges. Both material constituents and extracted chemicals should be identified and quantified.

R & D Function and Performance

  • Clinic-like treatments or implant

Complete Sterility Assurance Program

  • Sterilization validation
  • Environmental monitoring
  • Packaging validation

Biocompatibility

  • Cytotoxicity by MEM Elution
  • Irritation by intracutaneous or mucosal tissue exposure
  • Acute systemic toxicity using aqueous and non-aqueous extracts
  • Sensitization/Allergenicity using aqueous and non-aqueous extracts

Additional tests that may be required

  • Implant study in muscle or subcutaneous tissue
  • Series of genotoxicity assays (generally three)
  • Subchronic toxicity study or repeated application

This document provides a general overview of gastro-intestinal device evaluations. NAMSA Technical Specialists and Scientists will partner with you to develop a cost effective program and minimize your time to market. Our experts will help you design specific test programs based on the unique characteristics of each device.

NEED HELP?

Tell us what you need.

Or call us:

866.666.9455 (within the U.S.)
419.666.9455 (outside the U.S.)